Histamine H3 receptor activation decreases kainate-induced hippocampal gamma oscillations in vitro by action potential desynchronization in pyramidal neurons

被引:24
作者
Andersson, Richard [1 ]
Lindskog, Maria [1 ]
Fisahn, Andre [1 ]
机构
[1] Karolinska Inst, Dept Neurosci, Neuronal Oscillat Lab, SE-17177 Stockholm, Sweden
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2010年 / 588卷 / 08期
基金
瑞典研究理事会;
关键词
NETWORK OSCILLATIONS; SCHIZOPHRENIA; BRAIN; TRANSMISSION; ANTAGONIST; COGNITION; CHANNELS; SYSTEM; MEMORY;
D O I
10.1113/jphysiol.2009.180984
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
The study of rhythmic electrical activity in slice preparations has generated important insights into neural network function. While the synaptic mechanisms involved in the generation of in vitro network oscillations have been studied widely, little is known about the modulatory influence exerted on rhythmic activity in neuronal networks by neuropeptides and biogenic amines. Gamma oscillations play an important role in cognitive processes and are altered or disrupted in disorders such as Alzheimer's disease (AD) and schizophrenia. Given the importance of gamma oscillations for learning, memory and cognition processes as well as the recent interest in histamine H-3 receptors in the development of pro-cognitive drugs to treat disorders such as AD and schizophrenia, it is relevant to study the impact of histaminergic mechanisms on network gamma oscillations. Here we show for the first time a modulation of gamma oscillation by histaminergic mechanisms. Selective activation of the H-3 receptor by R-alpha-methylhistamine significantly reduces the power of kainate-induced gamma oscillations, but not carbachol-induced gamma oscillations, in the rat hippocampal slice preparation without affecting oscillation frequency. This effect is neither caused by a decrease in excitatory or inhibitory postsynaptic currents, nor a decrease in cellular excitability. Instead, we find that the decrease in oscillation power following H-3 receptor activation results from a desynchronization of pyramidal neuron action potential firing with regard to the local field potential oscillation cycle. Our data provide a possible mechanism of action for histamine in regulating gamma oscillations in the hippocampal network.
引用
收藏
页码:1241 / 1249
页数:9
相关论文
共 28 条
[1]
Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons [J].
Castillo, PE ;
Malenka, RC ;
Nicoll, RA .
NATURE, 1997, 388 (6638) :182-186
[2]
The effects of general anaesthetics on carbachol-evoked gamma oscillations in the rat hippocampus in vitro [J].
Dickinson, R ;
Awaiz, S ;
Whittington, MA ;
Lieb, WR ;
Franks, NP .
NEUROPHARMACOLOGY, 2003, 44 (07) :864-872
[3]
Reporting ethical matters in The Journal of Physiology: standards and advice [J].
Drummond, Gordon B. .
JOURNAL OF PHYSIOLOGY-LONDON, 2009, 587 (04) :713-719
[4]
Drutel G, 2001, MOL PHARMACOL, V59, P1
[5]
Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro [J].
Fisahn, A ;
Pike, FG ;
Buhl, EH ;
Paulsen, O .
NATURE, 1998, 394 (6689) :186-189
[6]
Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations [J].
Fisahn, A ;
Contractor, A ;
Traub, RD ;
Buhl, EH ;
Heinemann, SF ;
McBain, CJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (43) :9658-9668
[7]
Neuregulin-1 Modulates Hippocampal Gamma Oscillations: Implications for Schizophrenia [J].
Fisahn, Andre ;
Neddens, Joerg ;
Yan, Leqin ;
Buonanno, Andres .
CEREBRAL CORTEX, 2009, 19 (03) :612-618
[8]
STIMULUS-SPECIFIC NEURONAL OSCILLATIONS IN ORIENTATION COLUMNS OF CAT VISUAL-CORTEX [J].
GRAY, CM ;
SINGER, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1698-1702
[9]
Histamine in the nervous system [J].
Haas, Helmut L. ;
Sergeeva, Olga A. ;
Selbach, Oliver .
PHYSIOLOGICAL REVIEWS, 2008, 88 (03) :1183-1241
[10]
Modulation of hippocampal theta oscillation by histamine H3 receptors [J].
Hajos, M. ;
Siok, C. J. ;
Hoffmann, W. E. ;
Li, S. ;
Kocsis, B. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (01) :391-398